Justin R. Savage

Dr. Savage has been directing operations at GlycoMira for the past 12 years. Prior to joining the GlycoMira team, Dr. Savage worked at Prolexys Pharmaceuticals where he was instrumental in the preparation of the company’s IND submission to the Drug Oncology Products Division of the FDA and in supporting the development of oncology compounds from preclinical studies through a Phase 1 clinical trial. He has deep technical expertise in biochemistry, proteomics, and pharmaceutical research and has been instrumental in developing and validating the analytical assays to measure the potency and stability of active pharmaceutical ingredients. Dr. Savage has extensive experience in directing, coordinating and managing the technical and operational activities of the Company. He is an inventor on multiple patents and has served as the Principal Investigator on several SBIR grant awards totaling over $2M. Dr. Savage earned a doctorate degree in Biochemistry from Brigham Young University.